![Joseph Shulman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 30/06/2026
Joseph Shulman is Chief Technical Officer at Rhythm Pharmaceuticals, Inc. since 2022, with employment at the company starting in 2020.
Formerly, Mr. Shulman was Senior Vice President-Technical Operations at RA Pharmaceuticals, Inc. from 2019 to 2020 and Senior Vice President-Global Technical Operations at Novelion Therapeutics, Inc. from 2014 to 2019.
Education includes an MBA from Boston University and an undergraduate degree from the University of Miami.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/02/2026 | 18.970 ( 0,03% ) | 2 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 27/07/2020 |
| Società | Posizione | Fine |
|---|---|---|
| RA PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2020 |
| NOVELION THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
